Advancing Science in the Battle against Cancer
Our Mission:
Develop novel Therapeutic, Diagnostic, and Drug delivery tools
that will alter how and when we treat
Arming Doctors With Better Tools
Today's cancer treatment methods often employ a "shotgun" approach because we lack the tools to determine the cancer's next move. Taking advantage of the fact that cancer cells can hijack the body's normal wound healing processes provides us with insight into cancer cell behavior. By studying how cancer cells utilize the inflammatory pathway triggered by our treatments to proliferate and metastasize, we have developed a novel treatment that blocks these pathways to improve current treatments.
Heading Metastasis Off At The Pass
Encyt research has demonstrated that surgery, chemotherapy and radiation therapies trigger a distinct cytokine response that is expressed within a narrow window of time after treatment. Furthermore, our work has confirmed that a group of distinct cytokines foster rapid stem cell proliferation and EMT in tissue culture systems. Based on this work we have focused on blocking these cytokines as a novel treatment for cancer in collaboration with our research partners the Dr. Szewczuk lab at Queens University.